A
10b5-1 Plan
$ Value
$0
Shares
16,078
Price
$0
Filed
May 9
Insider
Name
BURKE WILLIAM W
Title
—
CIK
0001200612
Roles
Director
Transaction Details
Transaction Date
2025-05-07
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
51,820
Footnotes
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. | Adoption date of referenced 10b5-1(c) plan is: 05-28-2024 | Consists of shares sold to cover taxes associated with the settlement of stock units.
Filing Info
BURKE WILLIAM W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-09 | CBLL | M | $22K |
| 2025-12-09 | CBLL | ▼ | $214K |
| 2025-12-09 | CBLL | M | $108K |
| 2025-12-09 | CBLL | ▼ | $506K |
| 2025-12-09 | CBLL | M | $0 |
| 2025-12-09 | CBLL | M | $0 |
| 2025-11-13 | ATGE | F | $38K |
| 2025-11-12 | ATGE | A | $140K |
| 2025-06-10 | CBLL | A | $0 |
| 2025-06-05 | ATGE | ▼ | $294K |
Other Insiders at TCMD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pearson Andrea | — | — | 2026-03-09 |
|
Dodd Sheri Louise
Chief Executive Officer
|
— | $749K | 2026-02-24 |
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
|
— | $306K | 2026-02-24 |
|
Birkemeyer Elaine M.
CHIEF FINANCIAL OFFICER
|
— | $379K | 2026-02-24 |